Toxicology Letters

Article	Citations
The role of CK2 in the regulation of mitochondrial autophagy induced by rotenone	59
Neurotoxic implications of gliotoxin and ochratoxin A in SH-SY5Y cells: ROS-induced apoptosis and genotoxicity	46
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo	38
Evaluation of the causal effects of perfluorooctanesulfonate on COVID-19 and its associated mechanisms: Integrated Mendelian randomization and network toxicology analyses	38
Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRs	36
Isoflucypram: A new fungicide with no thyroid related endocrine disrupting properties and an overall favorable mammalian safety profile	36
Editorial Board	34
S-17-01 Dietary and inhalation exposure to nano- and microplastic particles: potential implications for human health	32
Metabolic activation and hepatic cytotoxicity of osthole mediated by cytochrome P450 enzymes	32
Corrigendum to “Review of the genotoxicity of "Arvin compounds", drinking water contaminants formed by the degradation of antioxidants in polyolefin pipes” [Toxicol. Lett. 402 (2024) 81–90]	30
Constructed wetlands to face water pollution: effective role of water hyacinth and the potential effects of this process on plant toxicity	28
P12-18 Investigating the role of nuclear receptors in valproic acid-induced liver steatosis	27
In memoriam: Antero Aitio, Professor (1943–2023)	27
LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics	26
P03-12 Physiologically based kinetic modelling (PBK) using QIVIVE to predict the toxicokinetic profiles of triazoles via oral route of administration	25
P05-26 A comprehensive set of structural keys for N-Nitrosamine fingerprinting and determining surrogate relevance in Carcinogenic Potency Assessments	24
OS01-02 New strategy of genotoxicity test using organoids in the 3-dimensional tissue culture system	23
P06-13 Mitoxantrone disrupts brain glutathione defence and the metabolic pathways in CD-1 mice	23
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline	21
P16-05 Exposure to carbon nanoparticle impairs cognitive functions by modulation of neurotrophic factors in rat hippocampus	21
P19-19 Evaluation of a Next Generation Risk Assessment framework for Developmental and Reproductive Toxicity	21
S28-01 Garbage In, Garbage Out: Mitigating the Ethical Risks of Artificial Intelligence and Machine Learning	21
P13-27 Toxicological evaluation of verbascoside from the viewpoint of genotoxicity	21
P12-12 Elucidation of molecular initiating events in PFAS – mediated cholestatic liver injury	20
P20-16 The unwritten expectations from FDA on biomedical device testing	20

P20-33 Creating a chemical, sensory and risk assessment profile of tobacco products, within the context of regulatory toxicology	20
P08-07 Prenatal developmental toxicity evaluation of higher olefins in Sprague-Dawley Rats	20
S01-04 Advancing mixture risk assessment from a regulatory point of view	20
P25-25 Dietary cumulative risk assessment of pesticide residues having effects on kidneys	20
P21-51 Does 5G exposure activate UCP1 adaptive non-shivering thermogenesis?	20
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations	19
P21-33 Damage towards human red blood cells by brominated flame retardants (BFRs) – molecular aspects	19
P01-42 In vitro test methods and petroleum UVCB substances: critical review of dosing methods	19
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals	19
P04-08 Insights into the mechanistic pathways underlying the neurotoxic effects of 2C-I and 25I-NBOMe drugs	18
P25-10 Update of European Food Safety Authority (EFSA)'s work on cumulative risk assessment of pesticide residues targeting the thyroid	18
OS03-09 When a model gives you trouble: handling hazard assessments for thousands of predicted (bio)degradation products	18
P05-43 What does it take to make a PBK for a pesticide in a NGRA framework? Evaluation of the kinetic space of pesticides and how to model it using open-source tools	18
P23-14 Multimodal pulmonary clearance kinetics of carbon black nanoparticles deposited in the lungs of rats: a role of alveolar macrophages	18
P02-06 New Approach Methodologies for hepatotoxic hazard assessment: development of an in vitro human liver fibrosis model	17
CEC03-02 Pharmacology/Immunology	17
P07-24 Analysis of genes expressed differently in alveolar macrophages of smokers, non-smokers and individuals with and without lipopolysaccharide exposure	17
P10-08 Evaluation of real-life PFAS mixture toxicity and impact on 3D placenta spheroid model	17
P21-71 Expanding fish invitrome-based methods as alternatives to animal use in aquatic toxicity testing	17
S26-03 Challenges posed by real-life exposure scenarios: a systems toxicology approach to integrated assessment of multiple risks	17
P19-28 Exposure data to cosmetic products of consumers presenting atopic dermatitis	16
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies	16
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark	16
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity	16
P10-19 A comparative study of the cytotoxic effects of cannabidiol and minor cannabinoids on placental trophoblast cells	16
P19-74 Platform for transfer models for hazardous compounds in animal feed	15
S23-02 Assessment and modelling of metabolites: the conazole case study	15
LP-18 Simultaneous determination of 5 kinds of virulent mushroom toxinsin human whole blood by ultra performance liquid chromatography- tandem mass spectrometry	15
P19-40 Risk assessment of AFB1 due to CYP3A4-mediated biotransformation with a highly sensitive human intestinal model	15
S25-04 Into the SEND data-verse: with great virtual power comes great regulatory responsibility	15
P15-05 Comparison between bisphenol A and its major substituent, bisphenol S, in terms of affecting the inflammatory process through the production of inflammatory mediators	15
P06-12 Deconvolution of multiple effect signatures in plasma metabolomics data using BMD modelling, concordance and complementarity of molecular points of departure derived from in vivo transcriptomic	15
LP-06 In Vitro assessment of hepatotoxicity of 15 pyrrole-based compounds on cellular and sub-cellular level in isolated rat hepatocytes and HPLC quantitative evaluation of the least toxic agent	15
P16-11 Effects of subacute oral exposure to sulforaphane on hematological parameters in rats	14
P07-19 Levels and temporal trend of phthalates in the Greenlandic adults during 2000–2019	14
P21-63 Towards an understanding of the relative toxicity of nanoparticles from different transport sources	14
P20-21 Toxicological testing strategy of a series of gas oils substances under REACH	14
S02-01 Data Science in derisking drug target and chemistry	14
OS04-02 Development of an innovative human-based testing battery for assessing thyroid hormone mediated developmental neurotoxicity	14
P14-05 Knock-down of FOXO3, GATA2, NFE2L2 and AHR promotes doxorubicin-induced cardiotoxicity in human cardiomyocytes	14
LP-07 3D lung spheroid model reveals silica-driven fibrosis via oxidative stress and apoptosis inhibition	14
P12-07 Early detection of hepatotoxic compounds in drug development: leveraging the potential of human liver microtissues for predictive screening	14
S29-01 Identification of phosphoproteomics changes for adverse outcome pathway development in neurotoxicant risk assessment	14
P02-25 Use of organotypic gingival cultures for nicotine pouch assessment	14
P11-01 BPS and BPF by acting as mitochondrial disrupting chemicals cause changes in energy metabolism in human ovarian granulosa cells	13
P01-02 In vitro identification of the possible immunotoxic potential of RNA drugs focusing on four specific stress pathways	13
P01-22 Anticancer effect of arsenic compounds on apoptosis in oral cavity cancer cells	13
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands	13
P10-07 Polystyrene micro – and nanoplastics induced spermatogenesis disorder via disturbance of mitochondrial dynamics in mice	13
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury	13

P02-28 Microfluidics technology as a tool to improve maturation and drug metabolism capacity of stem cell-derived hepatocytes in vitro	13
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations	13
P02-47 A rat in vitro 3D airway model for translational toxicology	13
P05-45 Ontology maps: data integration tools for applications in toxicology	13
P05-01 Ensuring in silico models for toxicology are FAIR	13
P23-09 Occupational dermal exposure assessment: an overview of the most relevant exposure estimation tools	13
Co-modification with MSC membrane and PDA prevents Fe3O4-induced pulmonary toxicity in mice via AMPK-ULK1 axis	12
S20-03: Relevance of endocrine disruption testing and assessment using animal and mechanistic studies for humans	12
P02-35 3D primary human kidney tissue model for nephrotoxicity	12
P01-13 Inhibition of lung surfactant function in vitro and breathing pattern changes in mice after exposure to plant protection products	12
Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo	12
Development of an automated cognitive behavioral testing method for juvenile mice in a group-housed environment and its application to developmental neurotoxicological study	12
S20-01 Principles of quantitative In Vitro to in vivo extrapolation (QIVIVE) applying physiologically based kinetic (PBK) modelling for DNT IVB	12
S24-04: Next Generation Risk Assessment: An industry perspective on the application of toxicogenomics and the challenges for implementation	12
P01-06 Validating multi-ion channel inhibition assays following best practice considerations	12
Chronic oral exposure to short chain chlorinated paraffins induced testicular toxicity by promoting NRF2-mediated oxidative stress	12
Gentamicin administration leads to synaptic dysfunction in inner hair cells	12
S15-01: Modelling kinetics and dynamics of chemicals at the US-EPA using the httk open-source platform	12
S08-01 Endocrine disrupting chemicals (EDCs)-Receptor for activated C kinase 1 (RACK1) liaison: from bridging the immune and the endocrine systems to EDC screening tool	12
The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice	12
OS04-09 Alkylated naphthalene toxicity varies across alkyl carbon number and position: insights from embryonic zebrafish exposures and transcriptomics	12
Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites	12
HUB Organoids™ improve pre-clinical toxicology, metabolism, and pharmacokinetic studies for drug discovery and development	11
LP-10 Experimental Evaluation of Skin Toxicity of Vesicant Chemicals and the Effectiveness of a New Complex Treatment	11
Usage patterns of facial cosmetic products in Asia	11
LP-18 A protocol to study transfer of bictegravir in dually perfused human placenta	11
S26-01: Evaluation of Microphysiological Systems combining skin models and systemic organs to elucidate the influence of application scenarios on the bioavailability, metabolic fate and biological eff	11
Acute phase response and inflammation in mice following exposure to metal oxide nanoparticles	11
A Tool for Tanimoto Similarity Clustering of Chemical Compounds	11
Using mechanisms of toxic action (MechoA) to strengthen skin sensitisationpredictionsfor chemicals and their metabolites	11
Multi-modal approach for prediction of skin toxicity in small molecules	11
Evaluation of larval zebrafish as an alternative whole-animal model for nephrotoxicity testing	11
OS03-10: Predictive Modeling of Deltamethrin Exposure in Fetal Brain Tissue: Implications for Human Health Risk Assessment	11
P16-41: The Effects of Glyphosate and its Metabolite Aminomethylphosphonic Acid on Apoptosis and Epigenetic Mechanisms in HepG2 Cell Cultures	11
LP-07 In silico analysis using Derek and Sarah along with ICH M7 expert review accurately predicts Mutagenicity and Carcinogenicity of Nitrosamines	11
Comparing the impact of multi-walled carbon nanotubes between murine and human lung epithelial cell models in vitro	11
LP-46 Organ-on-a-chip meets high throughput screening: measuring trans endothelial electrical resistance	11
OS02-01: Novel clinical phenotypes and chemical classifications in drug-induced cholestasis: analysis of a database of 390 patients developed by collaborative literature review and machine learning su	11
Validation and specificity testing of an in vitro method assessing substance-induced DIO1 inhibition in human liver microsomes	11
Applicability domain of the GARD® skin Medical Device test for in vitro skin sensitization testing of medical devices	10
Occupational welding exposure and lung cancer-related epigenetic modifications	10
Editorial Board	10
LP-47 Effect of environmentally relevant doses of BPA exposure on MCF-7 cells	10
Antibodies against a single fraction of Micrurus dumerilii venom neutralize the lethal effect of whole venom	10
Role of CinA in the regulation of inflammatory cytokines in keratinocytes: is Nrf2 the only regulator?	10
Adaptation of the in vitro Micronucleus Assay (OECD 487) for the Assessment of the Mutagenic Potential of Nanoparticles	10
LP-51 Epidermal Growth Factor Receptor and AXL as probable targets to alleviate drug-induced steatosis in HepG2 cells	10
Application of conformal prediction for in silico definition of molecular initiating events linked to endocrine disruption	10
How the EMMC MODA can be used for physic-based and data-based models for risk assessment?	10
In vitro assessment of the skin sensitizing potential and potency of epoxy resin monomers and pre-polymer mixtures using the GARD assay	10
Micro-sized polyethylene particles decrease cell viability and increase mitochondrional superoxide production in human colorectal adenocarcinoma Caco-2 cells	10
Effect of thimerosal over hypoxia-related factors in glioblastoma	10
Exploring potential structure-activity relationships of graphene-based materials.	10
LP-25 Assessing the impacts of oral exposure to microplastics on human health	10
LP-70 Toxicity of graphene nanomaterials in HEK 293T cells – effects of surface modifications by thermal treatment	10
Batch-to-batch variation of Ames test results for S. typhimurium TA 98 and TA 100 correlates with growth kinetics	10
Toxic effects of methyl ketones in the insect model species Nasonia vitripennis: potential alternatives to synthetic insecticides?	10
The effect of alkyl substitution on Polycyclic Aromatic Hydrocarbons (PAHs) that may be present in the mineral oils on their oxidative metabolism	10
Comparison of the effects of flavone cirsimarin on the proliferation, migration, and invasion of MCF-7 cells grown in 2D monolayer and 3D multicellular tumor spheroids	10
Wide-spread PFAS contamination of drinking water in Sweden - exposure and health risk assessment	9
Mutations in the filaggrin gene determine immune response after dermal chemical exposure	9
Cytotoxicity and anti-inflammatory properties of a novel lingonberry-based dietary supplement	9
Selenium Health Benefit Values, a biomarker for tunna mercury risk assessments	9
Modification of root microRNAs expression and exudation of wheat in response to bisphenol A contamination	9
Editorial Board	9
P21-31 Criteria for selecting physiologically-based kinetic models for use in developing new models for data-poor analogues via a read-across approach	9
Editorial Board	9
The disrupting effect of chlormequat chloride on growth hormone is associated with pregnancy	9
Strontium, Rubidium and Titanium in three marine species for human consumption: blue crab, sea bass & mussel	9
Toxicological assessment of leachates and leached substances from degraded plastic species using in-vitro bioassays	9
Assessment of the toxic effects of 2-dodecanone in the insect model species Drosophila melanogaster	9
In Vitro Toxicity Screening of an Inclusive Panel of Engineered Nanomaterials using an Advanced 3D Liver Model.	9
P22-18 The linkage between cadmium and insulin resistance – integrating bioinformatics approach with Benchmark modeling of human data	9
How to increase confidence in the defined approach for skin sensitisation with propyl paraben?	9
The safety of artificial sweeteners examined by an integrated metabolomics and gut bacterial profiling approach of Acesulfame K and Saccharin treated Wistar rats	9
Impact of sub-acute acrolein inhalation on the molecular regulation of mitochondrial metabolism in rat lung	9
Editorial Board	9
Early pathways of toxicity triggered by 3,4-methylene-dioxypyrovalerone unveiled by in vivo toxicometabolomics	8
Evaluation of liver fibrosis by human hepatic stellate cell spheroids	8
P06-18 Influence of extremely low frequency magnetic fields on the development of childhood leukemia – an experimental study in a susceptible mouse model	8

P18-07: A pesticide, fludioxonil, induced mitochondrial toxicity by increasing reactive oxygen species production and decreasing mitochondrial membrane potential in cardiomyocytes	8
The secretome of mesenchymal stem cells ameliorates the cytotoxic effects of doxorubicin in non-tumoral cells	8
P05-03 Photobiomodulation-induced Nrf2 partially controls the inflammatory response in keratinocytes	8
P22-19 Benchmark dose-response analyses for multiple endpoints in drug safety evaluation	8
Hazard assessment of disinfection by-products, bromo chloroacetic acid and bromo dichloroacetic acid, in drinking water	8
P22-24 Identification of the applicability domain for the use of read-across in food safety – development of read-across concept integrating metabolites	8
Use of fomepizole (4-methylpyrazole) for acetaminophen poisoning: A scoping review	8
P21-27 Use of non-animal approaches for pesticide safety assessment	8
P22-04 Assessment of low-dose ethanol in food	8
P21-14 Predictive tool for absorption during toxicokinetic evaluation of chemicals under REACH	8
Cytotoxicity of carbon nanofibers with different physicochemical properties	8
Cytotoxic and Antiproliferative Effects of ‘Brachydin C' in DU-145 Cells Grown in 3D Multicellular Tumor Spheroids	8
P17-36: Ti-alloy (TiAl6Nb7) metal powder toxicity in human embryonic kidney (HEK-293T) cell line	8
P22-29 Virtual human platform for safety assessment (VHP4Safety): assessing the safety of chemicals and pharmaceuticals based on human data	8
Evaluation of biological and epigenetic marks after exposure of MucilAir® human bronchial epithelia to mixtures of gaseous and particulate pollutants	8
P22-20 Risk assessment of Nanocrystal Formulated Zileuton (a poorly soluble BCS-II oral drug) using In Vivo Model	8
A pharma stepwise approach to the evaluation of Nitrosamines in drug products: regulatory scenario and the role of in silico approaches	8
Analysis of murine liver mRNA expression, DNA methylation, and histone after repeated exposure to chemicals	8
Strategic Use of High-Throughput Transcriptomics and Phenotypic Profiling Data in Support of Regulatory Decisions	8
P22-12 Benchmark dose response modelling of gene co-expression networks in hepatocytes exposed to known inducers of liver steatosis, cholestasis and necrosis	8
Relating early cellular events to Drug-Induced Liver Injury (DILI) using time-resolved transcriptomic and histopathology data	8
P04-19 Selecting drug like structures using in silico tools	8
P17-27: Role of oxidative stress in microplastic polymethyl methacrylate (PMMA)-induced hepatotoxicity with HepG2/THP-1 co-culture model	8
Detection of dexamethasone administration in veal calves: transcriptional biomarkers validation in FFPE muscle samples	8
Quercetin protects SH-SY5Y cells against sterigmatocystin-induced toxicity: prevention of NF-kB nuclear translocation and down regulation of HO-1 expression	8
LP-08 Permitted Daily Exposure (PDE) assessment of data-poor pharmaceutical impurities using read-across (RA) approach: A case study with selected siloxane compounds	8
Unravelling the molecular mechanisms of the adverse events after Bio-Alcamid® injection	8
P22-17 Acrylamide exposure estimates in the EuroMix biomonitoring study using a probabilistic approach	8
S-08-02 Biodistribution and biological activity of 2D nanomaterials: role of the protein corona	7
OS01-08: The role of mitochondria in nanoparticle-specific stem cell toxicity	7
P09-48: Comparison of the impact of bisphenols A, F and S on endocrine secretion of human placental cells: the bad, the ugly, where is the good?	7
P03-16: Effect of benzylisoquinoline alkaloids on camptothecin-resistant topoisomerase I	7
SOC-I-05 Histone modification, DNA methylation, and mRNA expression analysis of murine liver repeatedly exposure to a chemical	7
P09-31: Fludioxonil enhanced the development of the multinucleate-giant cancer cells related to cancer metastasis, chemo-resistance, and cancer stemness as an endocrine-disrupting chemical in triple-n	7
P09-20: A novel test battery for the fast and sensitive detection of hormonal effects of endocrine-disrupting chemicals based on the Arxula adeninivorans biosensor system with bioluminescence detectio	7
OS02-03: Combining an AOP-centred IATA and read across to derive a skin sensitisation point of departure for Next Generation Risk Assessment	7
P19-03: Oxidative damage in liver tissue induced by low doses exposure to a mixture of lead and polychlorinated biphenyls: Subacute toxicity study in rats	7
P19-09: Mixture effects of co-formulants and two plant protection products in a liver cell line	7
P06-22 Reproductive and developmental toxicity testing of a complex UVCB: implications of current dose setting advice under REACH for generating meaningful study outcomes	7
SOC-I-02 From in-vitro to in-vivo evaluation of a new nutraceutical ingredient obtained from kiwiberry (Actinidia arguta) leaves	7
P10-05: The relationship between environmental air pollution, meteorological factors, and emergency service admissions for epileptic attacks in children	7
P09-45: Effects of gestational exposure to α-cypermethrin on epigenetic parameters in placentas of Wistar rats	7
S-09-01 Thyroid hormones, pregnancy and offspring development in humans and correlation to animals	7
S19-03: The reduction of microplastic pollution – from sources to sinks: An environmental engineering perspective	7
P09-35: Aggravation of toxic effect of bisphenol A via oxidative and endoplasmic reticulum stress in the liver of obese female rats	7
S-03-02 Development of T2 MRI biomarker of neurotoxicity as a noninvasive quantitative approach	7
P09-34: Unraveling hormonal dependencies and associated species-specificities of neurodevelopmental key events to improve EDC risk assessment	7
S-05-01 Safe materials and products by design: designing nanomaterials through hazard assessment to humans and the environment early in the development stage of development process	7
S29-03: Impact of Flame Retardants in Residential Furnishings of Potential Chronic Toxicity of Smoke	7
P05-07 IFN-γ and TNF-α enhances immunosuppressive and skin regenerative effects of MSC-derived secretome	7
P19-05: Comparison of in vitro and in vivo study results for classification of plant protection products	7
P05-06 Protective role of peroxiredoxin V against UVB-induced apoptosis of epidermal keratinocytes	7
S23-04: Making quantitative AOP Networks into Usable Tools for Risk Assessment	7
P09-17: The pesticide active substance CB1 shows increased thyroxin-glucuronidation in rat and dog but not in human hepatocytes in vitro	7
P09-46: Preliminary results of the second National Human Biomonitoring program in Slovenia: bisphenols, parabens, PFAS, glyphosate and trace elements in children and adolescents	7
S-09-03 Model development of a THM in adult rat versus human rat thyroid hormone concentrations in serum	7
SOC-I-06 Differentially expressed microRNAs in human bronchial epithelial cells after exposure to nanofibrillar, microfibrillar or nanocrystalline cellulose	7
P02-02: Evaluation of urinary safety biomarker panel to improve monitoring of preclinical Antisense Oligonucleotide-induced tubular kidney toxicity	7
S-05-04 Oxidative potential and oxidative stress as key markers in an early-stage hazard assessment strategy for safe by design – SAbyNA	7
SOC-I-03 Advanced qualitative and quantitative 3t3 neutral red uptake tests for more physiologically relevant in vitro phototoxicity assessment	7
P01-01: A quantitative adverse outcome pathway for predicting medium-term lung function evolution after switching from combustible cigarettes to heated tobacco products	7
P09-39: The estrous cycle is one of the biomarkers of a chemical's endocrine disruptor properties	7
P03-20: Adverse (geno)toxic effects of bisphenol A its two analogues BPAP and BPC and their complex mixtures in a 3D HepG2 cell model	7
OS04-05: Blood-brain barrier on-a-chip to study compound-induced disruption	7
P06-03 Effects of antiepileptic drugs on the human fetal testis ex vivo	7
P17-33: Interaction of nanoplastics with intestinal epithelia: effect on permeability	7
P09-04: Di-(2-ethylhexyl) phthalate induce reactive oxygen species generation and inhibits sex-steroid hormone production in mice Leydig cells in vitro	7
S-01-03 Integrating in vitro distribution kinetics analysis in IVIVE-PBK	7
S-09-04 How can a testing strategy to identify a human-relevant thyroid hormone disruptor look like	7
P13-16: Inhibition of the macrophage response to Staphylococcus aureus infection after exposure to metal ions released from orthopaedic implants	6
S-13-01 Using existing knowledge for the risk evaluation of crop protection products to guide exposure driven data generation strategies	6
P10-11: Associations between blood levels of trace elements and cardiovascular risk factors in patients with rheumatoid arthritis	6
S-11-04 Rapid development of vaccines in challenging times	6
P13-10: In vitro evaluation of immunotoxicity of bisphenol A analogues using human lymphoblastoid cell lines	6
S04-03: CBD Regulatory and safety aspects	6
S-22-02 The screening and identification of substances with endocrine activity following an IATA workflow model	6
P14-06: Inhalation toxicity assessment of powder cosmetic products with an in vitro pulmonary model	6
SOC-III-11 The key characteristics of cancer hazards identified by the IARC Monographs Programme	6
S-17-02 Prioritization of contaminants for evaluation in food by WHO/FAO expert committees	6
P10-22: The effects of Perfluorooctanoic acid (PFOA) on edible vegetables germination and development	6
S-11-03 Accelerated timelines for non-clinical studies to support COVID-19 vaccine (AZD1222, ChAdOx1-nCov19)	6
P13-09: Influence of Extremely Low Frequency Magnetic Fields on the Developing Immune System – An Experimental Study in a Leukemia-Prone Mouse Model	6
P13-07: High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin	6
S03-01: The design and conduct of Extended One-Generation Reproductive Toxicity studies (EOGRTS)	6
SOC-III-03 Pulmonary toxicity of graphene based materials is governed by size-dependant biodegradation and clearance in alveolar phagocytes	6
SOC-IV-07 Using Xenopus laevis as a model organism for drug induced cardiotoxicity	6
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms	6
P14-03: Transcriptomic alterations induced by air pollution-derived ultrafine particles in lungs of mice chronically exposed	6
P10-10: Sublethal effects of antidepressants in planktonic protozoans and crustaceans	6
P10-09: Toxicological aspects of the Horizon EDIAQI project	6
P10-15: Impact of the physical and chemical part of fine particles (PM2.5–0.3) on human bronchial epithelial cells obtained from healthy and asthmatic donors	6
S-26-02 Nrf2-Keap1 system	6
SOC-IV-10 Glyphosate and its formulations Roundup Bioflow and RangerPro alter bacterial and fungal community composition in the rat caecum microbiome	6
P14-05: Measuring mucin content and the ratio of goblet cells in three-dimensional cultures of normal human bronchial epithelial cells by confocal microscopy	6
P14-01: Emissions from modern engines induce distinct effects in human olfactory mucosa cells, depending on fuel and aftertreatment	6